Therapeutic problems in disseminated encephalomyelitis (multiple sclerosis)
Payk, T.R.
Therapie der Gegenwart 112(3): 349-350
1973
ISSN/ISBN: 0040-5965 PMID: 4573496 Document Number: 63115
Document emailed within 1 workday
Related Documents
Lebrun, C.; Ghetau, G.; Bourg, V.; Chanalet, S.; Chatel, M. 2005: Relapsing remitting multiple sclerosis or multiphasic disseminated encephalomyelitis? Revue Neurologique (Paris) 161(2): 228-233Mal'tsev, D.V. 2014: Unresolved problems and the prospects for research in area of the multiple sclerosis: virologic, immunologic and therapeutic aspects Likars'ka Sprava 2014(5-6): 3-19
Spirin, N.N.; Baranova, N.S.; Fadeeva, O.A.; Shipova, E.G.; Stepanov, I.O. 2011: Differential aspects of multiple sclerosis and chronic borrelial encephalomyelitis Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 111(7): 8-12
Mackay, I.R.; Carnegie, P.R.; Coates, A.S. 1973: Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis Clinical and Experimental Immunology 15(4): 471-482
Macheret, E.L.; Iarosh, A.A.; Korchemnyĭ, V.A.; Panchenko, L.P. 1987: Morphological comparisons of disorders in multiple sclerosis and experimental allergic encephalomyelitis Vrachebnoe Delo 12: 64-68
Martirosian, V.V.; Vilkov, G.A.; Miliutin, L.V.; Mitiureva, F.I.; Khoruzhaia, T.A. 1974: Several components of the kinin system in multiple sclerosis and experimental allergic encephalomyelitis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(8): 1165-1168
Rose, L.M.; Richards, T.; Alvord, E.C. 1994: Experimental allergic encephalomyelitis (EAE) in nonhuman primates: a model of multiple sclerosis Laboratory Animal Science 44(5): 508-512
Cendrowski, W. 1972: Antilymphocytic globulin and its immunosuppressive action in experimental allergic encephalomyelitis and multiple sclerosis Neurologia i Neurochirurgia Polska 6(4): 619-623
Zaprianova, E.; Deleva, D.; Bakalska, M.; Filchev, N. 1997: Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis Morfologiia 112(6): 25-28
Barinsky, I.F.; Grebennikova, T.V.; Alkhovsky, S.V.; Kochergin-Nikitsky, K.S.; Sergeyev, O.V.; Gribencha, S.V.; Raev, S.A. 2015: Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis Voprosy Virusologii 60(4): 14-18
Alvord, E.C.; Hruby, S.; Shaw, C.M.; Slimp, J. 1984: Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases Progress in Clinical and Biological Research 146: 359-363
Stefferl, A.; Brehm, U.; Linington, C. 2000: The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis Journal of Neural Transmission. Supplementum 2000(58): 123-133
Gonsette, R.E. 1982: Therapeutic aspects of multiple sclerosis Bulletin de la Societe Belge d'Ophtalmologie 199-200: 275-280
Sas, G.; Boros, M. 1980: Actual diagnostic and therapeutic problems of disseminated intravascular coagulation (DIC) Therapia Hungarica 28(4): 153-161
Itoyama, Y. 1995: Multiple Sclerosis--diagnosis and its problems Rinsho Shinkeigaku 35(12): 1496-1497
Chofflon, M. 2003: Multiple sclerosis: current therapeutic strategies Revue Medicale de la Suisse Romande 123(1): 27-32
Chancellor, M.B.; Blaivas, J.G. 1994: Urological and sexual problems in multiple sclerosis Clinical Neuroscience 2(3-4): 189-195
Edan, G.; Coustans, M. 2000: Is immunosuppression a future therapeutic strategy for multiple sclerosis? Pathologie-Biologie 48(2): 114-120
Edan, G. 1998: New therapeutic strategies for multiple sclerosis: unanswered questions Revue Neurologique (Paris) 154(12): 813-815
Maciejek, Z. 1990: Multiple sclerosis--biochemical-immunologic and therapeutic aspects Wiadomosci Lekarskie 43(5-6): 232-239